The Current cover image

This new drug could be a game-changer for HIV/AIDS

The Current

00:00

Differences from existing PrEP options

Darrell contrasts lenacapavir with oral PrEP and injectable cabotegravir, highlighting dosing and administration benefits.

Play episode from 03:37
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app